Get the Stockscreener App
15.79
3.61%
0.55
After Hours:
15.70
-0.09
-0.57%
Uniqure N V Stock (QURE) Latest News
uniQure Announces Favorable Recommendation from Independent - GlobeNewswire
UniQure Gets Favorable Recommendation From Data Monitoring Committee AMT-162 Trial to Treat Amyotrophic Lateral Sclerosis - Marketscreener.com
Game-Changing ALS Treatment: uniQure's Gene Therapy Hits Critical Milestone - StockTitan
HC Wainwright Has Negative View of uniQure FY2024 Earnings - MarketBeat
uniQure (NASDAQ:QURE) Shares Down 4.8%Here's Why - MarketBeat
HC Wainwright Forecasts uniQure FY2029 Earnings - MarketBeat
H.C. Wainwright sets uniQure stock price target at $70 By Investing.com - Investing.com Canada
The Hidden Gem in Biotechnology? It’s Time to Take Notice - Jomfruland.net
Is uniQure N.V. (QURE) the Most Promising Growth Stock According to Wall Street Analysts? - Yahoo Finance
HC Wainwright Raises uniQure (NASDAQ:QURE) Price Target to $70.00 - MarketBeat
H.C. Wainwright sets uniQure stock price target at $70 - Investing.com
12 Most Promising Growth Stocks According to Wall Street Analysts - Insider Monkey
Assenagon Asset Management S.A. Sells 197,775 Shares of uniQure (NASDAQ:QURE) - MarketBeat
Brokers Offer Predictions for uniQure FY2025 Earnings - MarketBeat
JPMorgan Chase & Co. Sells 270,042 Shares of uniQure (NASDAQ:QURE) - MarketBeat
uniQure (QURE) Stock Price, News & Analysis - MarketBeat
Royal Bank of Canada Reaffirms Outperform Rating for uniQure (NASDAQ:QURE) - MarketBeat
(QURE) Technical Pivots with Risk Controls - Stock Traders Daily
Hemophilia B Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - The Globe and Mail
Sanders Morris Harris LLC Increases Stake in uniQure (NASDAQ:QURE) - MarketBeat
Here’s Why uniQure N.V. (QURE) Is Skyrocketing - MSN
Short Interest in uniQure (NASDAQ:QURE) Declines By 21.2% - MarketBeat
Why These 24 Stocks Are Skyrocketing - Insider Monkey
12 Best Growth Stocks to Buy and Hold in 2025 - Insider Monkey
Is uniQure N.V. (QURE) Among the Best Growth Stocks to Buy and Hold in 2025? - Insider Monkey
(QURE) Trading Signals - Stock Traders Daily
uniQure sets $17 share price for $75 million offering By Investing.com - Investing.com Nigeria
uniQure (NASDAQ:QURE) Receives $33.88 Consensus Target Price from Brokerages - MarketBeat
uniQure (NASDAQ:QURE) Sees Strong Trading VolumeStill a Buy? - MarketBeat
uniQure sets $17 share price for $75 million offering - Investing.com India
uniQure Announces Pricing of its Public Offering - The Manila Times
uniQure Prices $75 Million Public Offering at $17.00 Per Share to Boost Growth Capital - StockTitan
uniQure Announces Proposed Public Offering - The Manila Times
uniQure Announces Public Offering of Ordinary Shares and Pre-Funded Warrants - StockTitan
UniQure stock soars to 52-week high, hits $18.5 amid robust gains - Investing.com Canada
uniQure (NASDAQ:QURE) Sets New 1-Year HighHere's What Happened - MarketBeat
uniQure (NASDAQ:QURE) Shares Down 3.5%What's Next? - MarketBeat
uniQure (NASDAQ:QURE) Shares Gap DownHere's What Happened - MarketBeat
Uniqure stock soars to 52-week high, reaches $18.14 By Investing.com - Investing.com Canada
Uniqure stock soars to 52-week high, reaches $18.14 - Investing.com India
How the (QURE) price action is used to our Advantage - Stock Traders Daily
uniQure (NASDAQ:QURE) Shares Gap UpStill a Buy? - MarketBeat
UniQure stock soars to 52-week high, hits $17.75 amid robust gains By Investing.com - Investing.com South Africa
UniQure stock soars to 52-week high, hits $17.75 amid robust gains - Investing.com Nigeria
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):